| abstract |
The present invention refers to new sulfonamide derivatives, of general formula (la, lb, lc) optionally in the form of one of their stereoisomers, preferably enantiomers or diastereomers, their racemate, or in the form of a mixture of at least two of their stereoisomers, preferably enantiomers or diastomers, at any mixture ratio or their salts, preferably the corresponding, physiologically acceptable salts, or corresponding solvates; to the process for their preparation, to their application as medicaments in human and/or veterinary therapeutics, and to the pharmaceutical compositions containing them. |